Zylox-Tonbridge Medical Technology Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Jonathon Zhao
Chief Executive Officer (CEO)
CN¥17.4m
Compensación total
| Porcentaje del salario del CEO | 17.3% |
| Permanencia del CEO | 11.5yrs |
| Participación del CEO | 12.8% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 3.2yrs |
Actualizaciones recientes de la dirección
Recent updates
Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon
Apr 23
Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate
Jan 18Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?
Sep 21There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price
Aug 03We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jun 30Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?
Mar 08We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jan 19Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Jul 06We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely
Jan 27Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Oct 05Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | CN¥17m | CN¥3m | -CN¥79m |
| Sep 30 2023 | n/a | n/a | -CN¥101m |
| Jun 30 2023 | n/a | n/a | -CN¥124m |
| Mar 31 2023 | n/a | n/a | -CN¥119m |
| Dec 31 2022 | CN¥21m | CN¥3m | -CN¥114m |
| Sep 30 2022 | n/a | n/a | -CN¥135m |
| Jun 30 2022 | n/a | n/a | -CN¥155m |
| Mar 31 2022 | n/a | n/a | -CN¥178m |
| Dec 31 2021 | CN¥16m | CN¥2m | -CN¥200m |
| Sep 30 2021 | n/a | n/a | -CN¥168m |
| Jun 30 2021 | n/a | n/a | -CN¥135m |
| Mar 31 2021 | n/a | n/a | -CN¥118m |
| Dec 31 2020 | CN¥10m | CN¥1m | -CN¥100m |
| Dec 31 2019 | CN¥1m | CN¥746k | -CN¥67m |
Compensación vs. Mercado: La compensación total de Jonathon($USD2.92M) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD394.47K).
Compensación vs. Ingresos: La compensación de Jonathon ha sido consistente con los resultados de la empresa en el último año.
CEO
Jonathon Zhao (55 yo)
11.5yrs
Permanencia
CN¥17,389,000
Compensación
Dr. Zhong Zhao also known as Jonathon, serves as Director of Avinger, Inc. since March 04, 2024. He is Founder of Zylox-Tonbridge Medical Technology Co., Ltd. and serves as its Chairman since November 06,...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 11.5yrs | CN¥17.39m | 12.83% CN¥ 432.3m | |
| Senior VP of Sales & Marketing and Executive Director | 6.2yrs | CN¥10.53m | sin datos | |
| Senior VP | 5.3yrs | CN¥8.37m | 1.54% CN¥ 51.8m | |
| Independent Non-Executive Director | 3.2yrs | CN¥200.00k | sin datos | |
| Non-Executive Director | 3.4yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 3.2yrs | CN¥200.00k | sin datos | |
| Non-Executive Director | 3.6yrs | sin datos | sin datos | |
| Non Executive Director | 2yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 3.2yrs | CN¥200.00k | sin datos | |
| Employee Supervisor | 3.2yrs | sin datos | sin datos | |
| Supervisor | 2yrs | sin datos | sin datos | |
| Chairman of the Board of Supervisors | less than a year | sin datos | sin datos |
3.2yrs
Permanencia media
50.5yo
Promedio de edad
Junta con experiencia: La junta directiva de 2190 se considera experimentada (3.1 años de antigüedad promedio).